Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.H. Nüßlein, Manuela Le Bars, Michael T. Nurmohamed et al.|PubMed|2016Cited by 32
Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody StatusMelanie Hagen, Jürgen Rech, Matthias Englbrecht et al.|The Journal of Rheumatology|2018Cited by 11